U.S. Stock Market News | Weight-loss drug Zepbound expected to be approved in Japan next year, Eli Lilly up more than 1%

Zhitong
2024.10.11 15:01
portai
I'm PortAI, I can summarize articles.

On Friday, Eli Lilly's stock price fluctuated upwards, rising by 1.18% to $921.435 at the time of publication. On the news front, Eli Lilly's CEO stated on Friday that the weight loss drug Zepbound is expected to be approved in Japan next year

According to the Smart Finance app, on Friday, Eli Lilly (LLY.US) stock price fluctuated upwards, rising by 1.18% to $921.435 at the time of publication. On the news front, Eli Lilly's CEO stated on Friday that the weight-loss drug Zepbound is expected to be approved in Japan next year

Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.